Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors - A case study to compare the performances of several types of mixing in disposable bags with stainless

ADVERTISEMENT

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors
A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


BioPharm International


Target Protein Production


Figure 5. Molecule titer in production phase at the maximum working volume for disposable bioreactors, a 1,250 L MSB production bioreactor, and a 3.6 L process development bioreactor. Data are the means from two bioreactors, with errors bars representing minimum and maximum levels.
Concentration of the protein was measured by semi-automatic equipment with 10% of accuracy. Figure 5 shows protein concentration (molecule titer), and Figure 6 shows protein concentration measured during runs but taking into account the accuracy of the method.


Figure 6. Recombinant protein titer in production phase at maximum working volume for disposable bioreactors, a 1,250 L MSB production bioreactor, and a 3.6 L process development bioreactor. Data are the means from two bioreactors, with errors bars representing minimum and maximum levels with 10% accuracy of the quality control method.
Despite different mixing technologies, lower IVC, and higher viability in orbital shaking bioreactor, all disposable bioreactors demonstrated consistent protein concentration.

Their production performances seemed to be closer to process development bioreactors than production bioreactors.

When the accuracy of the quality control (QC) method was taken into account, protein concentration differences between bioreactors were less obvious.

Process variability taking into account QC accuracy seemed to be higher in disposable bioreactors than traditional bioreactors. This statement is not surprising as this process was better handled in traditional bioreactors than in new equipment.

Target Protein Quality Attributes

A recombinant protein was chosen for this project because its glycosylation pattern depended on cell culture conditions.


Figure 7. Recombinant protein quality for disposable bioreactors and 1250L MSB production bioreactor. HMW is for high molecular weight molecule (aggregates). High molecular weight molecules could not be compared to 1250L production bioreactors due to differences in sample treatment. Data are means from 2 bioreactors with errors bars representing minimum and maximum levels.
Quality attributes (Figure 7) are critical for protein function, pharmacokinetics variables such as half-life and bioavailability, immune response. They also may depend on the upstream part of the production process.


Figure 8. The pH measured after injecting sodium hydroxide in disposable bioreactors
To generate a high quality molecule, a minimum specification for glycosylation was fixed (red line in Figure 7). All bioreactors performed beyond this specification: disposable bioreactors, whatever mixing type, did not have a critical impact on this quality attribute.

This observation also is valid for the aggregates; no major differences were observed between disposable bioreactors.

For that process, cell growth and viability profiles of disposable bioreactors were close to traditional bioreactors. The productivity of disposable bioreactors was similar to MSB bioreactors. No impact of the mixing type was observed on molecule quality attributes. The equipment can be used either as a seeding bioreactor or as a production bioreactor.


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here